Prevalence, Etiological Patterns and Factors Associated with Bacteraemia Among Febrile Children with Sickle Cell Anaemia in Jinja Regional Referral Hospital, Uganda
- PMID: 40657276
- PMCID: PMC12248708
- DOI: 10.2147/IDR.S527477
Prevalence, Etiological Patterns and Factors Associated with Bacteraemia Among Febrile Children with Sickle Cell Anaemia in Jinja Regional Referral Hospital, Uganda
Abstract
Background: Children with sickle cell anemia (SCA) are highly susceptible to bacterial infections. While studies in Sub-Saharan Africa have explored the prevalence and causes of bacteremia in SCA, no such data exist from Uganda. This study aimed to determine the prevalence, bacterial causes, and associated factors of bacteremia among febrile children with SCA at Jinja Regional Referral Hospital (JRRH).
Methods: We conducted a cross-sectional study among febrile children ≤18 years with confirmed SCA at JRRH. Data on sociodemographic, clinical, and laboratory variables were collected from caregivers and medical records. Blood samples were cultured using the BACTEC FX200 system and sensitivity for Kirby-Bauer disk diffusion. Descriptive statistics reported prevalence and etiology. Binary logistic regression was used to identify factors associated with bacteraemia, using SPSS v26. Statistical significance was set at p < 0.05.
Results: Of the 209 febrile children enrolled, 114 (54.5%) were male and 116 (55.5%) were under five years. Bacteremia was confirmed in 44 patients (21.1%). The most frequent isolate was Staphylococcus aureus (25/44, 56.8%), followed by Escherichia coli (8/44, 18.2%), Klebsiella pneumoniae (3/44, 6.8%), and Haemophilus influenzae (3/44, 6.8%). All isolates were resistant to gentamicin, ampicillin, penicillin, and ofloxacin. S. aureus showed good sensitivity to cloxacillin. Factors associated with bacteremia were low maternal education (aOR = 1.098; 95% CI: 1.007-1.197; p = 0.037), tachycardia (aOR = 1.116; 95% CI: 1.027-1.213; p = 0.010) and neutrophilia (aOR = 1.536; 95% CI: 1.363-1.731; p < 0.001).
Conclusion: Bacteremia was common among febrile children with SCA, with Staphylococcus aureus as the leading isolate. Blood cultures should be prioritized. Ampicillin and gentamicin were ineffective, whereas cloxacillin, cefotaxime, and other antibiotics with demonstrated sensitivity are recommended as empiric alternatives.
Keywords: Escherichia coli; Staphylococcus aureus; Uganda; bacteremia; prevalence; sickle cell anemia.
© 2025 Haji Ali et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest. We acknowledge that this manuscript was previously uploaded to Research Square as a preprint https://www.researchsquare.com/article/rs-4997354/v1.
Similar articles
-
Bacterial profile and antimicrobial susceptibility pattern of urinary tract infection among diabetic patients at Bule Hora University Teaching Hospital, Southern Ethiopia.Sci Rep. 2025 Jul 6;15(1):24112. doi: 10.1038/s41598-025-05782-8. Sci Rep. 2025. PMID: 40619446 Free PMC article.
-
Antibiotic Susceptibility Report of Bacteria Isolated From Blood Cultures of Neutropenic Sepsis Patients Undergoing Chemotherapy.Cureus. 2025 Jun 13;17(6):e85903. doi: 10.7759/cureus.85903. eCollection 2025 Jun. Cureus. 2025. PMID: 40656248 Free PMC article.
-
Antibiotics for exacerbations of asthma.Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2. Cochrane Database Syst Rev. 2018. PMID: 29938789 Free PMC article.
-
Folate supplementation in people with sickle cell disease.Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3. Cochrane Database Syst Rev. 2018. PMID: 29546732 Free PMC article.
-
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2. Cochrane Database Syst Rev. 2016. PMID: 27711980 Free PMC article.
References
-
- McGann PT, Nero AC, Ware RE Malik, P, Tisdale, J. Clinical features of β-thalassemia and sickle cell disease. In: Gene and Cell Therapies for Beta-Globinopathies. New York: Springer; 1013 ; 2017:doi: 10.1007/978-1-4939-7299-9_1 1–26. - DOI
LinkOut - more resources
Full Text Sources